Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program

Impact · against what's priced in

AVAI sees a slight positive catalyst as it formally initiates its diabetes cell therapy research program with Ospedale San Raffaele. While the venture is early-stage, the transition from planning to a joint steering committee meeting marks the start of the data-generation phase necessary for future valuation milestones.

AVAI+0.30

No priced-in read yet